Doxorubicin Completed Phase 1 Trials for Neoplasms / Hepatocellular Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00988195Study of Pegylated Human Recombinant Arginase for Liver Cancer